Kilquist syndrome: A novel syndromic hearing loss disorder caused by homozygous deletion of SLC12A2.


Journal

Human mutation
ISSN: 1098-1004
Titre abrégé: Hum Mutat
Pays: United States
ID NLM: 9215429

Informations de publication

Date de publication:
05 2019
Historique:
received: 22 07 2018
revised: 22 01 2019
accepted: 07 02 2019
pubmed: 12 2 2019
medline: 10 3 2020
entrez: 12 2 2019
Statut: ppublish

Résumé

Syndromic sensorineural hearing loss is multigenic and associated with malformations of the ear and other organ systems. Herein we describe a child admitted to the NIH Undiagnosed Diseases Program with global developmental delay, sensorineural hearing loss, gastrointestinal abnormalities, and absent salivation. Next-generation sequencing revealed a uniparental isodisomy in chromosome 5, and a 22 kb homozygous deletion in SLC12A2, which encodes for sodium, potassium, and chloride transporter in the basolateral membrane of secretory epithelia. Functional studies using patient-derived fibroblasts showed truncated SLC12A2 transcripts and markedly reduced protein abundance when compared with control. Loss of Slc12a2 in mice has been shown to lead to deafness, abnormal neuronal growth and migration, severe gastrointestinal abnormalities, and absent salivation. Together with the described phenotype of the Slc12a2-knockout mouse model, our results suggest that the absence of functional SLC12A2 causes a new genetic syndrome and is crucial for the development of auditory, neurologic, and gastrointestinal tissues.

Identifiants

pubmed: 30740830
doi: 10.1002/humu.23722
pmc: PMC6693334
mid: NIHMS1011904
doi:

Substances chimiques

SLC12A2 protein, human 0
Solute Carrier Family 12, Member 2 0

Types de publication

Case Reports Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

532-538

Subventions

Organisme : NHGRI NIH HHS
ID : U01 HG007943
Pays : United States
Organisme : Intramural NIH HHS
ID : Z99 HG999999
Pays : United States
Organisme : National Human Genome Research Institute of the National Institutes of Health
ID : U01HG007943
Pays : International

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Références

Cold Spring Harb Mol Case Stud. 2016 Nov;2(6):a001289
pubmed: 27900370
Nat Genet. 1999 Jun;22(2):192-5
pubmed: 10369265
Otolaryngol Clin North Am. 2015 Dec;48(6):1041-61
pubmed: 26443487
J Biol Chem. 2000 Sep 1;275(35):26720-6
pubmed: 10831596
Am J Hum Genet. 2003 Mar;72(3):621-35
pubmed: 12577201
Acta Otorhinolaryngol Ital. 2012 Dec;32(6):347-70
pubmed: 23349554
Am J Physiol Cell Physiol. 2018 Aug 1;315(2):C258-C276
pubmed: 29719172
Am J Physiol Cell Physiol. 2001 Aug;281(2):C615-23
pubmed: 11443061
J Biol Chem. 1999 Sep 17;274(38):26946-55
pubmed: 10480906
J Neurosci. 2012 Sep 26;32(39):13630-8
pubmed: 23015452
Arch Dis Child. 2015 Mar;100(3):271-8
pubmed: 25324569
Am J Physiol Cell Physiol. 2013 Apr 15;304(8):C693-714
pubmed: 23325410

Auteurs

Ellen F Macnamara (EF)

National Institutes of Health Undiagnosed Diseases Program, Common Fund, Office of the Director, Bethesda, Maryland.
Office of the Clinical Director, National Human Genome Research Institute National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland.

Alanna E Koehler (AE)

National Institutes of Health Undiagnosed Diseases Program, Common Fund, Office of the Director, Bethesda, Maryland.

Precilla D'Souza (P)

National Institutes of Health Undiagnosed Diseases Program, Common Fund, Office of the Director, Bethesda, Maryland.
Office of the Clinical Director, National Human Genome Research Institute National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland.

Tyra Estwick (T)

National Institutes of Health Undiagnosed Diseases Program, Common Fund, Office of the Director, Bethesda, Maryland.
Office of the Clinical Director, National Human Genome Research Institute National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland.

Paul Lee (P)

National Institutes of Health Undiagnosed Diseases Program, Common Fund, Office of the Director, Bethesda, Maryland.
Office of the Clinical Director, National Human Genome Research Institute National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland.

Gilbert Vezina (G)

Division of Diagnostic Imaging and Radiology, Children's National Health System, Washington, District of Columbia.
Common Fund, Office of the Director, National Institutes of Health, Bethesda, Maryland.

Harper Fauni (H)

Common Fund, Office of the Director, National Institutes of Health, Bethesda, Maryland.

Stephen R Braddock (SR)

National Institutes of Health Undiagnosed Diseases Program, Common Fund, Office of the Director, Bethesda, Maryland.

Erin Torti (E)

Department of Pediatrics, Saint Louis University School of Medicine, St. Louis, Missouri.

James Matthew Holt (JM)

Department of Pediatrics, Saint Louis University School of Medicine, St. Louis, Missouri.

Prashant Sharma (P)

HudsonAlpha Institute for Biotechnology, Huntsville, Alabama.

May Christine V Malicdan (MCV)

National Institutes of Health Undiagnosed Diseases Program, Common Fund, Office of the Director, Bethesda, Maryland.

Cynthia J Tifft (CJ)

National Institutes of Health Undiagnosed Diseases Program, Common Fund, Office of the Director, Bethesda, Maryland.
Office of the Clinical Director, National Human Genome Research Institute National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH